These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34398356)

  • 1. A physiologically based pharmacokinetic (PBPK) model to describe organ distribution of
    Siebinga H; de Wit-van der Veen BJ; Beijnen JH; Stokkel MPM; Dorlo TPC; Huitema ADR; Hendrikx JJMA
    EJNMMI Res; 2021 Aug; 11(1):73. PubMed ID: 34398356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A physiologically based pharmacokinetic model for [
    Siebinga H; de Wit-van der Veen BJ; Beijnen JH; Dorlo TPC; Huitema ADR; Hendrikx JJMA
    EJNMMI Res; 2023 Feb; 13(1):8. PubMed ID: 36735114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification.
    Velikyan I; Sundin A; Sörensen J; Lubberink M; Sandström M; Garske-Román U; Lundqvist H; Granberg D; Eriksson B
    J Nucl Med; 2014 Feb; 55(2):204-10. PubMed ID: 24379222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Pauwels E; Cleeren F; Tshibangu T; Koole M; Serdons K; Dekervel J; Van Cutsem E; Verslype C; Van Laere K; Bormans G; Deroose CM
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3033-3046. PubMed ID: 32617641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized Peptide Amount and Activity for ⁹⁰Y-Labeled DOTATATE Therapy.
    Kletting P; Kull T; Maaß C; Malik N; Luster M; Beer AJ; Glatting G
    J Nucl Med; 2016 Apr; 57(4):503-8. PubMed ID: 26678617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment planning in PRRT based on simulated PET data and a PBPK model. Determination of accuracy using a PET noise model.
    Hardiansyah D; Guo W; Attarwala AA; Kletting P; Mottaghy FM; Glatting G
    Nuklearmedizin; 2017 Feb; 56(1):23-30. PubMed ID: 27885372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically based pharmacokinetic modeling of (18)F-SiFAlin-Asp3-PEG1-TATE in AR42J tumor bearing mice.
    Maaß C; Rivas JR; Attarwala AA; Hardiansyah D; Niedermoser S; Litau S; Wängler C; Wängler B; Glatting G
    Nucl Med Biol; 2016 Apr; 43(4):243-6. PubMed ID: 27067044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-Head Comparison of
    Zhu W; Cheng Y; Wang X; Yao S; Bai C; Zhao H; Jia R; Xu J; Huo L
    J Nucl Med; 2020 Jun; 61(6):897-903. PubMed ID: 31676731
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of time-integrated activity coefficients in PRRT using simulated dynamic PET and a pharmacokinetic model.
    Hardiansyah D; Attarwala AA; Kletting P; Mottaghy FM; Glatting G
    Phys Med; 2017 Oct; 42():298-304. PubMed ID: 28739143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin receptor saturation after administration of high peptide amounts of [
    Siebinga H; Veerman CHAM; de Wit-van der Veen L; Stokkel MPM; Hendrikx JJMA; Aalbersberg EA
    EJNMMI Res; 2022 Dec; 12(1):74. PubMed ID: 36515683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hitherto unknown brain meningioma detected on
    Parghane RV; Talole S; Basu S
    World J Nucl Med; 2019; 18(2):160-170. PubMed ID: 31040748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.
    Jois B; Asopa R; Basu S
    Clin Nucl Med; 2014 Jun; 39(6):505-10. PubMed ID: 24662668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative biodistribution and radiation dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in patients with neuroendocrine tumors.
    Sandström M; Velikyan I; Garske-Román U; Sörensen J; Eriksson B; Granberg D; Lundqvist H; Sundin A; Lubberink M
    J Nucl Med; 2013 Oct; 54(10):1755-9. PubMed ID: 23929824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of patient-based treatment planning in peptide receptor radionuclide therapy.
    Hardiansyah D; Maass C; Attarwala AA; Müller B; Kletting P; Mottaghy FM; Glatting G
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):871-880. PubMed ID: 26577941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid kit-based (68)Ga-labelling and PET imaging with THP-Tyr(3)-octreotate: a preliminary comparison with DOTA-Tyr(3)-octreotate.
    Ma MT; Cullinane C; Waldeck K; Roselt P; Hicks RJ; Blower PJ
    EJNMMI Res; 2015 Dec; 5(1):52. PubMed ID: 26452495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parametric Net Influx Rate Images of
    Ilan E; Sandström M; Velikyan I; Sundin A; Eriksson B; Lubberink M
    J Nucl Med; 2017 May; 58(5):744-749. PubMed ID: 27789716
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
    Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
    J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting [
    Siebinga H; de Wit-van der Veen BJ; Beijnen JH; Stokkel MPM; Dorlo TPC; Huitema ADR; Hendrikx JJMA
    EJNMMI Phys; 2023 Aug; 10(1):48. PubMed ID: 37615812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric measurements of (68)Ga-high affinity DOTATATE: twins in spirit - part III.
    Hartmann H; Freudenberg R; Oehme L; Zöphel K; Schottelius M; Wester HJ; Wunderlich G; Kotzerke J; Brogsitter C
    Nuklearmedizin; 2014; 53(5):211-6. PubMed ID: 25029274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.